Propanc Biopharma (PPCB) Stock Statistics & Valuation Metrics

Propanc Biopharma has a market cap or net worth of $2.54M. The enterprise value is $2.10M.

Propanc Biopharma has 13,364,244 shares outstanding. The number of shares has decreased by -2.65% in one year.

Propanc Biopharma’s return on equity (ROE) is -4.24 and return on invested capital (ROIC) is -366.39%.

The current PE Ratio of Propanc Biopharma is ―. Propanc Biopharma’s PEG ratio is 0.00282.

In the last 12 months, Propanc Biopharma had revenue of 0.00 and earned -58.92M in profits. Earnings per share was -14.85.

In the last 12 months, operating cash flow was -2.11M and capital expenditures 5.00, giving a free cash flow of -2.11M billion.

Propanc Biopharma pays an annual dividend of ―, resulting in a dividend yield of ―

Propanc Biopharma upcoming earnings date is ―, ―.

Propanc Biopharma as a current ratio of 1.50, with Debt / Equity ratio of 1.18%

In the past 12 months, Propanc Biopharma has paid 0.00 in taxes.

Propanc Biopharma EV to EBITDA ratio is -0.31, with an EV/FCF ratio of -44.88.

Propanc Biopharma has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is 18.51%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Propanc Biopharma is ―, which is 11.43% higher than the current price. The consensus rating is ―